Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
1.
Dtsch Med Wochenschr ; 135(24): 1224-7, 2010 Jun.
Article in German | MEDLINE | ID: mdl-20533155

ABSTRACT

HISTORY AND CLINICAL FINDINGS: A 70-year-old woman was admitted to hospital with fatigue, pallor and shortness of breath on mild exertion. In her past medical history only borderline hypertension and allergy to penicillin were to note. INVESTIGATIONS: Actual laboratory findings revealed renal failure with metabolic acidosis and hyperkalaemia. A normochrome normocytic anemia and secondary hyperparathyreoidism were suggestive of a subacute course. The renal biopsy showed histological features of a subacute tubulo-interstitial nephritis. DIAGNOSIS, TREATMENT AND COURSE: The chronic renal failure caused by an interstitial nephritis was treated with corticosteroids and hemodialysis treatment was started. The trigger for AIN could not be found, there was no infectious or systemically disease nor a nephrotoxic medication identified. For nearly six months the patient had taken a homeopathic agent which is a dilution of penicillium chrysogenum. In case of a determined allergy to penicillin, an extract of the fungus producing penicillin could possibly cause an interstitial nephritis. The patient was dialysis-independent with a GFR about 8 - 10 ml/min at the time of discharge. CONCLUSION: With interstitial nephritis all agents should be considered a potential suspect, even homeopathic agents.


Subject(s)
Drug Hypersensitivity/complications , Homeopathy , Kidney Failure, Chronic/chemically induced , Nephritis, Interstitial/chemically induced , Penicillins , Penicillium chrysogenum , Phytotherapy/adverse effects , Plant Extracts/toxicity , Aged , Drug Hypersensitivity/diagnosis , Female , Glomerular Filtration Rate/drug effects , Humans , Kidney Failure, Chronic/diagnosis , Nephritis, Interstitial/diagnosis , Risk Factors
2.
Dtsch Med Wochenschr ; 127(19): 1013-6, 2002 May 10.
Article in German | MEDLINE | ID: mdl-11997868

ABSTRACT

HISTORY: A 29-year-old man had finger clubbing since the age of 15 years, and for the last 10 years his hands and feet had grown disproportionately. In addition he suffered from marked whole-body sweating, especially of the hands and feet, as well as persistent pain in the limbs and joints. INVESTIGATIONS: Biochemical and endocrinological tests were normal. Radiology of the hands and lower legs revealed marked periosteal thickening, while the substantia trabeculosa was unremarkable. Secondary causes having been excluded primary hypertrophic osteoarthropathy was diagnosed. TREATMENT AND COURSE: While there is no causal treatment, physio- and balneotherapy improved the symptoms. CONCLUSION: Early and accurate diagnosis of primary hypertrophic osteoarthropathy is essential, if only because of its favourable long-term prognosis.


Subject(s)
Osteoarthropathy, Primary Hypertrophic/diagnosis , Adult , Balneology , Diagnosis, Differential , Humans , Male , Osteoarthropathy, Primary Hypertrophic/therapy , Osteoarthropathy, Secondary Hypertrophic , Pain , Physical Therapy Modalities , Prognosis , Sweating
5.
J Nephrol ; 14(5): 424-7, 2001.
Article in English | MEDLINE | ID: mdl-11730279

ABSTRACT

A 19-year-old patient on chronic ambulatory peritoneal dialysis experienced severe neurologic disturbances caused by uremia. Increased signal intensity was seen bilaterally in the cortical and subcortical areas of the occipital and parietal lobe on cranial magnetic resonance imaging (MRI). Insufficient peritoneal dialysis efficacy was documented and the patient was switched from peritoneal to hemodialysis. Cranial MRI indicated a marked regression of the lesions to nearly normal, confirming the diagnosis of uremic encephalopathy.


Subject(s)
Brain Diseases, Metabolic/diagnosis , Uremia/complications , Adult , Brain Diseases, Metabolic/etiology , Equipment Failure , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/therapy , Magnetic Resonance Imaging , Male , Peritoneal Dialysis, Continuous Ambulatory , Uremia/metabolism
6.
Dtsch Med Wochenschr ; 126(45): 1265-8, 2001 Nov 09.
Article in German | MEDLINE | ID: mdl-11700567

ABSTRACT

HISTORY AND ADMISSION FINDINGS: A 36-year-old gardener was admitted for tonic-clonic seizures after binge drinking. The next days he developed massive rhabdomyolysis with acute renal failure. Past medical history was unremarkable except for a similar episode of acute renal failure 14 years ago. At that time he had consumed alcohol as well. Furthermore, the patient complained of exercise-related painful muscle cramping and swelling. INVESTIGATIONS: The serum creatinine peaked at 8.5 mg/dl, blood urea at 126 mg/dl and the maximal level of serum creatinine kinase was 108 300 U/l. Because of the massive rhabdomyolysis and the patient inverted question marks past medical history a metabolic myopathy was suspected and a muscle biopsy was performed. Histochemical staining of muscle frozen sections for phosphorylase revealed no activity which is typical for myophosphorylase deficiency (McArdle inverted question marks disease). Additional biochemical analysis of the muscle biopsy specimen confirmed the diagnosis. TREATMENT AND COURSE: By vigorous intravenous hydration and forced alkaline diuresis, the patient had a sufficient urinary output and lacked uremic signs. The serum creatinine and urea fell continuously and reached normal levels after 6 weeks. At that time serum creatinine kinase was still elevated (867 U/l), which is typical for McArdle inverted question marks disease. Avoiding alcohol, a new episode of rhabdomyolysis and acute renal failure did not occur. CONCLUSIONS: Besides exercise alcohol is likely to be a further possible trigger of rhabdomyolysis and acute renal failure in McArdle inverted question marks disease. Postulated mechanisms by which alcohol induces muscle injury include direct muscle toxicity and inhibition of gluconeogenesis, as these patients are probably more dependent on the gluconeogenetic pathway for muscle cell metabolism.


Subject(s)
Acute Kidney Injury/etiology , Alcoholic Intoxication/complications , Glycogen Storage Disease Type V/complications , Rhabdomyolysis/complications , Acute Kidney Injury/diagnosis , Acute Kidney Injury/therapy , Adult , Biopsy , Clinical Enzyme Tests , Creatine/blood , Creatine Kinase/blood , Diuresis , Diuretics/therapeutic use , Follow-Up Studies , Furosemide/therapeutic use , Humans , Male , Muscle, Skeletal/pathology , Rhabdomyolysis/diagnosis , Rhabdomyolysis/etiology , Rhabdomyolysis/pathology , Sodium Chloride/administration & dosage , Time Factors , Urea/blood
7.
Cell Tissue Res ; 305(1): 79-86, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11512674

ABSTRACT

Human peritoneal mesothelial cells (HMC) play an important role in inflammatory processes by their ability to produce various cytokines and chemokines, such as monocyte chemoattractant protein 1 (MCP-1) and interleukin 8 (IL-8). In this study we investigated the effect of experimentally generated hyaluronan (HA) fragments, degradation products of the extracellular matrix component hyaluronan, which accumulate at inflammatory sites, on the expression of MCP-1 and IL-8 in cultured HMC. MCP-1 and IL-8 mRNA expression was determined by RNase protection assays, and protein levels in the supernatants were measured by enzyme-linked immunosorbent assays. HA fragments with a molecular mass of approximately 1-7x10(5) daltons upregulate MCP-1 and IL-8 synthesis in HMC dose and time dependently. The effect of HA fragments could be blocked by Ro31-8220, a specific protein kinase C inhibitor, and by PD98059, an inhibitor of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Upregulation of chemokine synthesis was preceded by an increase in NF-kappaB and AP-1 DNA-binding activity, suggesting that these transcription factors are activated to increase MCP-1 and IL-8 expression by HA fragments. These data demonstrate that HA fragments markedly enhance the mRNA expression and protein synthesis of MCP-1 and IL-8 in HMC. In concert with previous findings, our observations indicate that enhanced levels of HA, which are present in the peritoneal cavity of peritoneal dialysis patients, may account for a locally increased chemokine production.


Subject(s)
Adjuvants, Immunologic/pharmacology , Chemokine CCL2/genetics , Hyaluronic Acid/pharmacology , Interleukin-8/genetics , Peritoneum/immunology , Adjuvants, Immunologic/chemistry , Cells, Cultured , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Epithelium , Flavonoids/pharmacology , Gene Expression/drug effects , Gene Expression/immunology , Humans , Hyaluronan Receptors/metabolism , Hyaluronic Acid/chemistry , Indoles/pharmacology , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/immunology , Molecular Weight , NF-kappa B/metabolism , Peptide Fragments/chemistry , Peptide Fragments/pharmacology , Peritoneal Dialysis , Peritoneum/cytology , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , RNA, Messenger/analysis , Transcription Factor AP-1/metabolism
8.
Kidney Int ; 60(1): 117-25, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11422743

ABSTRACT

BACKGROUND: The mesothelium has an important role in maintaining an adequate fibrinolytic capacity in the peritoneal cavity and thus in preventing the formation of fibrinous peritoneal adhesions by secreting the fibrinolytic enzyme tissue-type plasminogen activator (t-PA). The fibrinolytic activity of human mesothelial cells (HMCs) is counteracted by rapid uptake of t-PA via the low-density lipoprotein receptor-related protein (LRP). The 39 kD receptor-associated protein (RAP) is an inhibitor of binding of t-PA to LRP, but RAP itself is also rapidly degraded via LRP. METHODS: Adenovirus-mediated RAP gene transfer technology was used to evaluate the effect of prolonged overexpression of RAP on t-PA accumulation in conditioned medium of HMCs under basal and inflammatory conditions. RESULTS: Infection of HMCs with a recombinant adenovirus carrying the RAP cDNA resulted within one day in t-PA levels that were maximally twofold to threefold increased as compared with noninfected or adenovirus-beta-galactosidase-infected cells. Whereas upon prolonged incubation, t-PA levels in the conditioned medium of uninfected cells leveled off because of rapid uptake and degradation via LRP, t-PA concentrations in the medium of adenovirus-RAP-infected cells continued to increase, reaching fivefold control levels after 72 hours. The increased t-PA accumulation persisted for seven days and then slowly returned to control values over the next few weeks. In contrast, the production of a specific inhibitor of t-PA, plasminogen activator inhibitor-1 (PAI-1), was not affected by adenoviral RAP gene transfer. Northern blotting analysis showed that t-PA, PAI-1, and LRP mRNA concentrations were not changed after adenoviral infection, underlining that the elevated t-PA levels are the result of RAP-blocked uptake and degradation of t-PA rather than increased t-PA synthesis. RAP gene transfer also restored diminished fibrinolytic activity of cytokine-treated mesothelial cells. CONCLUSIONS: Adenovirus-mediated transfer of the RAP gene provides an efficient way of transiently increasing the fibrinolytic capacity of mesothelial cells.


Subject(s)
Carrier Proteins/pharmacology , Fibrinolysis/drug effects , Glycoproteins/pharmacology , Peritoneum/metabolism , Adenoviridae/genetics , Carrier Proteins/genetics , Cells, Cultured , Culture Media, Conditioned/metabolism , Down-Regulation , Drug Stability , Epithelial Cells/metabolism , Gene Transfer Techniques , Genetic Vectors , Glycoproteins/genetics , Humans , Immunoblotting , LDL-Receptor Related Protein-Associated Protein , Peritoneum/cytology , Peritonitis/metabolism , Peritonitis/pathology , Time Factors , Tissue Extracts/metabolism , Tissue Plasminogen Activator/antagonists & inhibitors , Tissue Plasminogen Activator/metabolism
10.
Nephron ; 87(4): 346-51, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11287779

ABSTRACT

Human peritoneal mesothelial cells (HMC) contribute to the activation and control of inflammatory processes in the peritoneum by their potential to produce various inflammatory mediators. The present study was designed to assess the effect of glucose, the osmotic active compound in most commercially available peritoneal dialysis fluids, on the synthesis of the C-C chemokine monocyte chemoattractant protein-1 (MCP-1) in cultured HMC. The MCP-1 concentration in the cell supernatants was determined by enzyme-linked immunosorbent assay and the MCP-1 mRNA expression was examined using Northern blot analysis. Incubation of HMC with glucose (30-120 mM) resulted in a time- and concentration-dependent increase in MCP-1 protein secretion and mRNA expression. After 24 h the MCP-1 synthesis was increased from 2.8 +/- 0.46 to 4.2 +/- 0.32 ng/10(5) cells (n = 5, p < 0.05) in HMC treated with 60 mM glucose. In contrast, osmotic control media containing either the metabolically inert monosaccharide mannitol or NaCl did not influence MCP-1 production. The stimulating effect of high glucose on MCP-1 expression in HMC was mimicked by activation of protein kinase C (PKC) with the phorbol ester PMA (20 nM). Coincubation of the cells with glucose and the specific PKC inhibitor Ro 31-8220 completely blunted glucose-mediated MCP-1 expression. In summary, our results indicate that glucose induces MCP-1 synthesis by a PKC-dependent pathway. Since osmotic control media did not increase MCP-1 release, it is suggested that the effect of glucose is mainly related to metabolism and not to hyperosmolarity. These data may in part explain elevated steady-state levels of MCP-1 found in the dialysis effluent of continuous ambulatory peritoneal dialysis patients.


Subject(s)
Chemokine CCL2/genetics , Epithelial Cells/physiology , Glucose/pharmacology , Protein Kinase C/metabolism , Transcription, Genetic/drug effects , Cells, Cultured , Chemokine CCL2/analysis , Enzyme-Linked Immunosorbent Assay , Epithelial Cells/cytology , Epithelial Cells/drug effects , Gene Expression Regulation/drug effects , Humans , Kinetics , Mannitol/pharmacology , Peritoneal Cavity , RNA, Messenger/genetics , Sodium Chloride/pharmacology
11.
Am J Kidney Dis ; 37(4): 815-9, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11273882

ABSTRACT

Human peritoneal mesothelial cells (HMCs) have a critical role in maintaining the intraperitoneal balance between fibrinolysis and coagulation by expressing the fibrinolytic enzyme, tissue-type plasminogen activator (tPA), as well as a specific plasminogen activator inhibitor (type 1; PAI-1). During bacterial peritonitis, the balance between intraperitoneal generation and degradation of fibrin is disturbed. As a consequence, severe peritoneal damage occurs, which is one of the leading causes of patient dropout from continuous ambulatory peritoneal dialysis (CAPD) therapy. Cultured HMCs isolated from omental biopsy specimens were used to study the effect of heat-killed strains (2 x 10(8)/mL) of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli on the synthesis of tPA and PAI-1. Conditioned media were obtained by incubating cells with the different bacterial strains. tPA and PAI-1 antigen concentrations were measured in the cell supernatants by enzyme-linked immunosorbent assay. Each of the three heat-killed microorganisms induced a time-dependent increase in PAI-1 synthesis. After a 48-hour incubation period, the strongest effect was seen in the presence of S aureus (3.5-fold versus control), followed by S epidermidis (2.5-fold versus control) and E coli (1.5-fold versus control). Under the same conditions, tPA antigen levels did not change after exposure to S aureus or E coli, whereas the addition of S epidermidis resulted in enhanced tPA antigen production (2-fold versus control). The increase in PAI-1 synthesis in the presence of the heat-killed microorganisms was preceded by similar changes in interleukin-1alpha (IL-1alpha) levels. Inhibiting the activity of IL-1alpha with a neutralizing antibody significantly reduced bacterial-induced PAI-1 production. Our results indicate that the fibrinolytic imbalance during bacterial peritonitis depends on the bacterial species. The increase in PAI-1 synthesis, not the decrease in the production of tPA, alters mesothelial fibrinolytic activity. Because the increase in PAI-1 expression is significantly quenched by blocking the activity of IL-1alpha, the mesothelial release of this cytokine is involved in bacterial-induced changes in the fibrinolytic system.


Subject(s)
Bacterial Vaccines/pharmacology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Interleukin-1/physiology , Peritoneal Dialysis, Continuous Ambulatory , Peritoneum/cytology , Peritoneum/metabolism , Plasminogen Activator Inhibitor 1/biosynthesis , Bacterial Vaccines/administration & dosage , Cells, Cultured , Epithelial Cells/immunology , Epithelium/drug effects , Epithelium/immunology , Epithelium/metabolism , Escherichia coli/immunology , Fibrinolysis/immunology , Humans , Interleukin-1/biosynthesis , Interleukin-1/immunology , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritoneum/immunology , Peritonitis/etiology , Peritonitis/immunology , Peritonitis/microbiology , Plasminogen Activator Inhibitor 1/immunology , Plasminogen Activator Inhibitor 1/metabolism , Staphylococcus aureus/immunology , Staphylococcus epidermidis/immunology , Tissue Plasminogen Activator/immunology , Tissue Plasminogen Activator/metabolism
12.
Clin Immunol ; 98(2): 244-8, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11161981

ABSTRACT

The frequency of carriers of the alpha1-antitrypsin (alpha1-AT) deficiency allele PI*Z is increased in patients with Wegener's granulomatosis (WG). The polymorphic protease inhibitor (PI) gene is part of a cluster of serine protease inhibitor (serpin) genes (AACT; alpha1-antichymotrypsin, PCI; protein C inhibitor, CBG; corticosteroid binding globulin, PIL; PI-like pseudogene) at chromosome 14q32.1. In this study we investigated whether the serpin gene cluster contributes to the background of Wegener's granulomatosis. Therefore, phenotyping of alpha1-AT was performed and simple tandem repeat polymorphisms (STRP) in the genes for CBG, PI, and PCI as well as two STRP (D14S55 and D14S48) flanking the centromeric and one (D14S51) flanking the telomeric region of the gene cluster were examined in a population of 79 patients with WG and 128 unrelated healthy controls. In WG patients an increased frequency of the PI*Z defective allele is demonstrated as well as a linkage disequilibrium between all members of this gene cluster plus the centromeric and telomeric STRP. These results indicate an involvement of the serpin genes in the pathogenesis of Wegener's granulomatosis and it is possible that other genes located in the vicinity of D14S55 or D14S51 contribute to the genetic background of the disease.


Subject(s)
Chromosomes, Human, Pair 14/genetics , Granulomatosis with Polyangiitis/genetics , Serine Proteinase Inhibitors/genetics , alpha 1-Antitrypsin Deficiency/genetics , alpha 1-Antitrypsin/genetics , Alleles , Centromere/genetics , Chromosome Mapping , Female , Gene Frequency , Genetic Predisposition to Disease , Germany , Humans , Isoelectric Focusing , Linkage Disequilibrium , Male , Phenotype , Protein C Inhibitor/genetics , Pseudogenes , Tandem Repeat Sequences , Telomere/genetics , Transcortin/genetics , White People , alpha 1-Antichymotrypsin/genetics
13.
Perit Dial Int ; 21(5): 487-94, 2001.
Article in English | MEDLINE | ID: mdl-11757833

ABSTRACT

OBJECTIVE: The continuous contact of glucose-containing peritoneal dialysis (PD) fluids with the peritoneum results in the intraperitoneal formation of early and advanced glycation end-products. This nonenzymatic glycation of proteins may cause morphological and functional alterations to the peritoneum, which may contribute to patient dropout from PD therapy. Because fibrinolytic system components have been demonstrated to play an important role in the balance of intraperitoneal generation and degradation of fibrin, we studied the effect of early and advanced glycated human serum albumin, methylglyoxal, and 3-deoxyglucosone on the synthesis of tissue-type plasminogen activator (tPA), as well as its specific inhibitor (PAI-1), in human peritoneal mesothelial cells (HPMC). METHODS: Antigen concentrations in the supernatants of cultured HPMC were measured by ELISA. Northern blot analysis was conducted for mRNA expression. Electrophoretic mobility shift assays were applied to demonstrate the involvement of the transcription factors nuclear factor kappa B (NF-kappaB) and activator protein-1 (AP-1) in signal transduction. RESULTS: Incubation of HPMC with early glycated albumin (GHSA) resulted in a time- and concentration-dependent increase in PAI-1 mRNA expression and antigen secretion. In contrast, no changes in PAI-1 synthesis occurred after stimulation with either the 1,2-dicarbonyl compounds methylglyoxal and 3-deoxyglucosone, or with late advanced glycation end-products. tPA synthesis was not affected by any of the tested components. Furthermore, HPMC exposed to GHSA induced NF-kappaB and AP-1 DNA binding activity, suggesting that GHSA-induced overexpression of PAI-1 is transcriptionally regulated by both transcription factors. CONCLUSIONS: We conclude that Amadori modified glycated albumin upregulates PAI-1 synthesis in HPMC, possibly mediated through the activation of the transcription factors NF-kappaB and AP-1. The present data support the clinical relevance of the formation of glycated proteins and their involvement in pathological processes in PD patients. Thus, glycated albumin may contribute to an imbalance between intraperitoneal formation and degradation of fibrin that causes peritoneal structural alterations, with subsequent membrane failure.


Subject(s)
Deoxyglucose/analogs & derivatives , Epithelial Cells/metabolism , Glycation End Products, Advanced/pharmacology , Plasminogen Activator Inhibitor 1/biosynthesis , Albumins/pharmacology , Animals , Blotting, Northern , Cells, Cultured , Deoxyglucose/pharmacology , Enzyme-Linked Immunosorbent Assay , Fibrinolysis , Humans , NF-kappa B/metabolism , Plasminogen Activator Inhibitor 1/genetics , Pyruvaldehyde/pharmacology , RNA, Messenger/analysis , RNA, Messenger/metabolism , Tissue Plasminogen Activator/biosynthesis , Tissue Plasminogen Activator/genetics , Transcription Factor AP-1/metabolism
14.
Nephrol Dial Transplant ; 15(8): 1207-11, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10910446

ABSTRACT

BACKGROUND: Chronic inflammatory disorders or infections represent a major cause of hyporesponsiveness to recombinant human erythropoietin (rHuEpo). To test the hypothesis that dialysate-related cytokine induction alters the response to rHuEpo, we conducted a prospective study with matched pairs of chronic haemodialysis patients. We compared the effect of two dialysis fluids, differing in their microbiological quality, on the rHuEpo therapy. METHODS: Thirty male patients with end-stage renal disease maintained on regular haemodialysis were assigned either to a group treated with conventional (potentially microbiologically contaminated) dialysate (group I) or to a group treated with online-produced ultrapure dialysate (group II). Randomization was stratified according to the maintenance dose of rHuEpo necessary to maintain a target haemoglobin level of 10-10.5 g/dl. Patients were followed for 12 months. Kt/V was calculated by the formula of Daugirdas. Haemoglobin levels were measured weekly and serum ferritin concentrations were determined at 6-week intervals. C-reactive protein (CRP) and interleukin-6 (IL-6) was measured by an ELISA at the start of the study and after 3, 6 and 12 months. RESULTS: In group I, continuous use of bicarbonate dialysate did not change the rHuEpo dosage given to achieve the target haemoglobin level and was associated with elevated surrogate markers (CRP, IL-6) of cytokine-induced inflammation. The switch from conventional to online-produced ultrapure dialysate in group II resulted in a lower bacterial contamination with a significant decrease of CRP and IL-6 blood levels. It was accompanied by a significant and sustained reduction of the rHuEpo dosage, which was required to correct the anaemia. Using multiple regression analysis, IL-6 levels are shown to have a strong predictive value for rHuEpo dosage in both groups. CONCLUSIONS: Our data demonstrate that dialysate-related factors such as low bacterial contamination can induce the activation of monocytes, resulting in elevated serum levels of IL-6. Dialysate-related cytokine induction might diminish erythropoiesis. The use of pyrogen free ultrapure dialysate resulted in a better response to rHuEpo. Not only would it save money, but it would also help to maintain an optimal haemoglobin level without further increase in rHuEpo dosage.


Subject(s)
Cytokines/blood , Dialysis Solutions/therapeutic use , Erythropoietin/therapeutic use , Renal Dialysis , Bacteria/isolation & purification , Bicarbonates/therapeutic use , Dose-Response Relationship, Drug , Drug Contamination , Erythropoietin/administration & dosage , Hemoglobins/analysis , Humans , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/therapy , Male , Middle Aged , Prospective Studies , Recombinant Proteins/therapeutic use
16.
Perit Dial Int ; 20(6): 778-83, 2000.
Article in English | MEDLINE | ID: mdl-11216574

ABSTRACT

OBJECTIVE: Recently, high levels of intraperitoneally generated thrombin were found in the effluent of patients treated with continuous ambulatory peritoneal dialysis (CAPD). The aim of the present study was to investigate in human peritoneal mesothelial cells (HMCs) the effect of thrombin on the activity and synthesis of matrix metalloproteinases (MMPs), which regulate the degradation of basement membrane collagen. METHODS: Cultured HMCs were isolated from omental tissue and used at confluence for the experiments. Conditioned media were obtained by incubating cells with serum-free M199 containing the relevant doses of thrombin. Activity of MMP-2 and MMP-9 were determined by an activity assay system. The antigen levels of MMPs and of the specific tissue inhibitor of metalloproteinases 1 (TIMP-1) were measured by ELISA. Northern blot analysis was applied to analyze mRNA expression of MMP-2 and TIMP-1. RESULTS: Incubation of HMCs with increasing doses of thrombin resulted in a concentration- and time-dependent suppression of MMP-2 activity. No changes in MMP-9 activity were seen. After a 48-hour stimulation period with thrombin (5 U/mL), MMP-2 activity decreased to 53% of that seen in control conditions. Antigen measurements revealed that this decrease was paralleled by a slight reduction in MMP-2 levels, which became significant at a thrombin dose of 5 U/mL [50.65 +/- 7.5 ng/10(5) cells (48 hours, 5 U/mL) vs 64.6 +/- 10.1 ng/10(5) cells (control)]. Under the same conditions, TIMP-1 levels were considerably increased [3.9 +/- 0.46 microg/10(5) cells (48 hours, 5 U/mL) vs 1.2 +/- 0.14 microg/10(5) cells (control)]. Hirudin (10 U/mL) completely inhibited the thrombin-induced effects on MMP-2 and TIMP-1 synthesis. These results were also reflected by Northern blot hybridization, where a slight decrease in MMP-2 and an increase in TIMP-1 mRNA expression were observed in response to thrombin. CONCLUSIONS: Our results suggest that high thrombin levels suppress MMP-2 activity through decreased MMP-2 and increased TIMP-1 synthesis. Thus, thrombin may promote the accumulation of basement membrane collagen. In addition to fibrin formation, this mechanism may represent a further contribution by thrombin to peritoneal thickening during CAPD.


Subject(s)
Epithelial Cells/enzymology , Matrix Metalloproteinase 2/metabolism , Peritoneum/cytology , Protease Inhibitors/metabolism , Thrombin/physiology , Tissue Inhibitor of Metalloproteinase-1/biosynthesis , Cells, Cultured , Hirudins/pharmacology , Humans , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase Inhibitors , Peritoneum/enzymology , RNA, Messenger/biosynthesis , Tissue Inhibitor of Metalloproteinase-1/genetics
17.
Clin Nephrol ; 53(5): 404-7, 2000 May.
Article in English | MEDLINE | ID: mdl-11305816

ABSTRACT

Peripheral polyneuropathies associated with monoclonal IgM gammopathy of undetermined significance often have a progressive course and optimal treatment has not been established. We report on a patient diagnosed with polyneuropathy associated with benign IgM gammopathy, who was successfully treated with antibody-based immunoadsorption only. The neurological symptoms of the patient improved continuously over six months of treatment. Controlled trials should be performed to define this indication for antibody-based immunoadsorption therapy.


Subject(s)
Immunoglobulin M/immunology , Immunosorbent Techniques , Monoclonal Gammopathy of Undetermined Significance/complications , Polyneuropathies/therapy , Humans , Male , Middle Aged , Monoclonal Gammopathy of Undetermined Significance/immunology , Polyneuropathies/immunology , Time Factors
18.
Clin Immunol ; 94(1): 9-12, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10607485

ABSTRACT

Wegener granulomatosis (WG), microscopic polyangiitis (MP), and Churg Strauss syndrome (CSS) are rare systemic autoimmune disorders. Common features are anti-neutrophil cytoplasmic antibodies (ANCA) in patient sera. Whereas WG patients show mainly anti-proteinase 3 ANCA, MP and CSS patients typically present anti-myeloperoxidase (MPO) ANCA. ANCA play an important role in the pathogenesis in the vessel wall by activating polymorphonuclear cells (PMN) and increased adhesivity between PMN and endothelial cells via adhesion molecules. Here we investigated major adhesion molecules as predisposition factors via common polymorphisms in or in the vicinity of the candidate genes ICAM-1, e-selectin, PLAUR, CD11b, and CD18. A restriction fragment-length polymorphism in exon 11 of the CD18 gene was associated with MPO-ANCA(+) systemic vasculitis. Our data indicate that a common variant of the CD18 gene confers increased risk for CSS and MP, supporting that genetic factors are involved in the etiology and pathogenesis of ANCA-associated systemic vasculitides.


Subject(s)
Antibodies, Antineutrophil Cytoplasmic/analysis , CD18 Antigens/genetics , Peroxidase/immunology , Vasculitis/immunology , Alleles , Antibodies/classification , E-Selectin/genetics , Humans , Intercellular Adhesion Molecule-1/genetics , Macrophage-1 Antigen/genetics , Microsatellite Repeats/genetics , Polymorphism, Genetic
19.
Perit Dial Int ; 19(4): 319-24, 1999.
Article in English | MEDLINE | ID: mdl-10507812

ABSTRACT

OBJECTIVE: To determine the influence of thrombin, which is generated intraperitoneally during peritoneal dialysis, on the synthesis of fibrinolytic system components in human peritoneal mesothelial cells (HMC). METHODS: Confluently grown HMC, isolated from the omental tissue, were used in the experiments. Conditioned media were obtained by incubating cells with serum-free M199 containing the appropriate concentration of the test compound. Tissue type plasminogen activator (tPA) and plasminogen activator inhibitor type 1 (PAI-1) antigen concentrations were measured by ELISA. Northern blot analysis was conducted for mRNA expression experiments. To test thrombin specificity, we used the thrombin inhibitor hirudin. The protein kinase C (PKC) inhibitor Ro 31-8220 was inserted to examine whether the effect of thrombin depends on PKC activity. RESULTS: Thrombin increased PAI-1 antigen in the conditioned media of HMC in a time- and concentration-dependent manner. After 24 hours incubation, PAI-1 levels increased from 350+/-30 ng/10(5) cells in control conditions to 620+/-30 ng/10(5) cells in HMC exposed to 5 U/mL thrombin (n = 8, p < 0.05). In contrast, there was no effect of thrombin on tPA antigen levels. An increase of PAI-1 mRNA expression was also observed by Northern blot hybridization. Hirudin (10 U/mL) inhibited the thrombin-induced increase in PAI-1 synthesis. In addition, a complete inhibition of the stimulating effect of thrombin on PAI-1 synthesis was obtained by blocking PKC activity with Ro 31-8220 (3 micromol/L). CONCLUSIONS: Thrombin increases PAI-1 synthesis in HMC via a PKC-dependent mechanism. Thereby the synthesis of tPA is not affected. Thus, thrombin may not only promote fibrin formation in the peritoneal cavity, but may also inhibit fibrin degradation by release of free PAI-1 from HMC.


Subject(s)
Epithelial Cells/metabolism , Peritoneum/metabolism , Plasminogen Activator Inhibitor 1/biosynthesis , Thrombin/physiology , Antithrombins/pharmacology , Blotting, Northern , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Hirudins/pharmacology , Humans , Indoles/pharmacology , Peritoneum/cytology , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/physiology , Tissue Plasminogen Activator/biosynthesis , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...